What is the price target for LIK stock?
6 analysts have analysed LIK.DE and the average price target is 660.45 EUR. This implies a price increase of 39.93% is expected in the next year compared to the current price of 472.
LIMES SCHLOSSKLINIKEN AG (LIK.DE) Forecast, Price Target & Analyst Ratings
FRA:LIK • DE000A0JDBC7
Current stock price
472 EUR
-10 (-2.07%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LIMES SCHLOSSKLINIKEN AG (LIK.DE).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
€660.45
Upside
+ 39.93%
From current price of €472.00 to mean target of €660.45, Based on 6 analyst forecasts
Low
€590.85
Median
€660.45
High
€745.50
Price Target Revisions
1 Month
-8.80%
3 Months
7.92%
Price Target Summary
6 Wall Street analysts provided a forecast for the next 12 months for LIK.DE. The average price target is 660.45 EUR. This implies a price increase of 39.93% is expected in the next year compared to the current price of 472.
The average price target has been revised upward by 7.92% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
LIK.DE was analyzed by 6 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about LIK.DE.
In the previous month the buy percentage consensus was at a similar level.
LIK.DE was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2025 - 2030
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 30.05M 19.09% | 37.956M 26.31% | 38.122M 0.44% | 53.631M 40.68% | 67.063M 25.05% | 76.431M 13.97% | N/A | N/A | N/A | |
| EBITDA YoY % growth | 8.653M | 7.672M -11.33% | 7.05M -8.11% | 13.544M 92.11% | 17.976M 32.72% | 21.3M 18.49% | 22.793M 7.01% | 25.563M 12.15% | 28.162M 10.17% | |
| EBIT YoY % growth | 5.998M 32.41% | 5.026M -16.21% | 4.289M -14.66% | 10.1M 135.49% | 16.362M 62.00% | 21.008M 28.40% | 19.402M -7.64% | 22.21M 14.47% | 24.845M 11.86% | |
| Operating Margin | 19.96% | 13.24% | 11.25% | 18.83% | 24.40% | 27.49% | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | 20.27 14.38% | 29.25 44.36% | 38.34 31.07% | N/A | N/A | N/A |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
29.35%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
20.30%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
44.48%
EBIT Next 5 Year
29.34%
LIMES SCHLOSSKLINIKEN AG / LIK.DE Forecast FAQ
Can you provide the expected long term growth rate for LIMES SCHLOSSKLINIKEN AG stock?
The expected long term growth rate for LIMES SCHLOSSKLINIKEN AG (LIK.DE) is 20.3%.